HomeAI · summaries
Storia in 2 fonti
Medtronic beats quarterly estimates on robust demand for heart devices
Irish-headquartered medtech giant working through spin out of diabetes business and focus on smaller, targeted acquisitions
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
irishtimes.com
Medtronic beats quarterly estimates on robust demand for heart devices
Irish-headquartered medtech giant working through spin out of diabetes business and focus on smaller, targeted acquisitions
- ·
benzinga.com
Why Is Medtronic Stock Gaining Wednesday? - Medtronic (NYSE:MDT)
Medtronic (MDT) stock jumps after beating Q4 revenue expectations, driven by strong growth in cardiovascular and diabetes tech.
- ·
Wall Street May Be Mispricing Medtronic, Analyst Says - Medtronic (NYSE:MDT)
BTIG upgrades Medtronic (MDT) to Buy with a $90 target after a strong Q4 revenue beat and accelerating organic growth. Read more.